The Efficacy of IntraCoronary Erythropoietin Delivery BEfore Reperfusion: Gauging Infarct Size in Patients With Acute ST-segment Elevation Myocardial Infarction (ICEBERG).
Phase of Trial: Phase III
Latest Information Update: 16 Oct 2015
At a glance
- Drugs Darbepoetin alfa (Primary)
- Indications Postmyocardial infarction
- Focus Pharmacodynamics
- Acronyms ICEBERG
- 07 Jun 2017 Biomarkers information updated
- 01 Aug 2012 Planned End Date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 06 Mar 2012 New trial record